SCARB1 and atherosclerosis: In contrast, scavenger receptor class B type I (SR-BI) is predominantly expressed in hepatocytes and steroidogenic cells, where it facilitates the uptake of HDL and enhances reverse cholesterol transport, emerging as a therapeutic target to reduce atherosclerosis development [151].